Trial

NCT02428231

Tecfidera Slow-Titration Study
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
Condition
Multiple Sclerosis
Intervention
dimethyl fumarate
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-05